Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Nephros Q3 EPS $(0.12) Misses $(0.10) Estimate, Sales $2.60M Miss $2.66M Estimate

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is unchanged from the same period last year. The company reported quarterly
byBenzinga Newsdesk
November 4, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.60 million which missed the analyst consensus estimate of $2.66 million by 2.26 percent. This is a 22.58 percent increase over sales of $2.12 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Tech Market In Focus After Big Friday Slide From Apple, Alphabet Following Judge’s Decision

By JJ Kinahan
Today, 11:46 PM
September has a bad reputation around Wall Street. It’s living up to that so far as last week was the worst in three months, but some green shoots pushed through the sidewalk cracks this morning as eyes turn to the Tech sector after a ragged Friday. 

AAPL

Read More

5 Value Stocks In The Consumer Defensive Sector

By Benzinga Insights
Today, 11:46 PM
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

ACU